Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains

[1]  D. Small.  The Role of the Amyloid Protein Precursor (APP) in Alzheimer's Disease: Does the Normal Function of APP Explain the Topography of Neurodegeneration? , 1998, Neurochemical Research.

[2]  M. D'Andrea,et al.  Intracellular accumulation of β-amyloid1–42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer’s disease , 2002, Neuroscience.

[3]  M. D'Andrea,et al.  Cerebellar diffuse amyloid plaques are derived from dendritic Aβ42 accumulations in Purkinje cells , 2002, Neurobiology of Aging.

[4]  Caine W. Wong,et al.  Altered Metabolism of the Amyloid β Precursor Protein Is Associated with Mitochondrial Dysfunction in Down's Syndrome , 2002, Neuron.

[5]  Peter Schubert,et al.  Glia-related pathomechanisms in Alzheimer's disease: a therapeutic target? , 2001, Mechanisms of Ageing and Development.

[6]  R. Mrak,et al.  The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer’s disease , 2001, Neurobiology of Aging.

[7]  Oliver Wirths,et al.  Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice , 2001, Neuroscience Letters.

[8]  D. Sparks,et al.  Quantitative assessment of possible age-related change in synaptic numbers in the human frontal cortex , 2001, Neurobiology of Aging.

[9]  J. Troncoso,et al.  Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. , 2001, Archives of pathology & laboratory medicine.

[10]  P. A. Peterson,et al.  Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease , 2001, Histopathology.

[11]  B. Barres,et al.  Control of synapse number by glia. , 2001, Science.

[12]  P. Andrade‐Gordon,et al.  Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease , 2001, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[13]  A. Araque,et al.  Dynamic signaling between astrocytes and neurons. , 2001, Annual review of physiology.

[14]  J. Nyengaard,et al.  Cellular Expression of α7 Nicotinic Acetylcholine Receptor Protein in the Temporal Cortex in Alzheimer's and Parkinson's Disease— A Stereological Approach , 2000, Neurobiology of Disease.

[15]  H. Schröder,et al.  Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. , 2000, Brain research. Molecular brain research.

[16]  P. A. Peterson,et al.  β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity , 2000, The Journal of Biological Chemistry.

[17]  A. Nordberg,et al.  Decreased Protein Levels of Nicotinic Receptor Subunits in the Hippocampus and Temporal Cortex of Patients with Alzheimer’s Disease , 2000, Journal of neurochemistry.

[18]  P. Greengard,et al.  Intraneuronal Aβ42 Accumulation in Human Brain , 2000 .

[19]  H. Braak,et al.  Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated Aβ deposits in the human entorhinal cortex , 2000, Acta Neuropathologica.

[20]  M. Svensson,et al.  Glial responses to synaptic damage and plasticity , 1999, Journal of neuroscience research.

[21]  D. Davies,et al.  β-Amyloid Immunoreactivity in Astrocytes in Alzheimer's Disease Brain Biopsies: An Electron Microscope Study , 1999, Experimental Neurology.

[22]  H. Schröder,et al.  Nicotinic acetylcholine receptors in Alzheimer's disease. , 1999, Journal of Alzheimer's disease : JAD.

[23]  K. Davis,et al.  Cholinergic markers in elderly patients with early signs of Alzheimer disease. , 1999, JAMA.

[24]  Veerle Baekelandt,et al.  Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.

[25]  P. Mcgeer,et al.  Occurrence of the diffuse amyloid β‐protein (Aβ) deposits with numerous Aβ‐containing glial cells in the cerebral cortex of patients with Alzheimer's disease , 1999 .

[26]  J. Silver,et al.  Glial fibrillary acidic protein is necessary for mature astrocytes to react to β‐amyloid , 1999 .

[27]  D. Thal,et al.  Diffuse plaques in the molecular layer show intracellular A beta(8-17)-immunoreactive deposits in subpial astrocytes. , 1999, Clinical neuropathology.

[28]  S. Scheff,et al.  Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease. , 1998, Journal of neuropathology and experimental neurology.

[29]  D. Selkoe,et al.  The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease , 1998 .

[30]  Y. Ihara,et al.  Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain. , 1998, The American journal of pathology.

[31]  Y. Ihara,et al.  Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques , 1998, Acta Neuropathologica.

[32]  W. Griffin,et al.  Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression , 1998, Brain pathology.

[33]  L. Thal,et al.  Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease , 1998, Journal of Neural Transmission.

[34]  J. Silver,et al.  Glial cell extracellular matrix: boundaries for axon growth in development and regeneration , 1997, Cell and Tissue Research.

[35]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[36]  I. Bechmann,et al.  Astrocytes and microglial cells incorporate degenerating fibers following entorhinal lesion: A light, confocal, and electron microscopical study using a phagocytosis‐dependent labeling technique , 1997, Glia.

[37]  L. Mucke,et al.  β-Secretase Processing of the β-Amyloid Precursor Protein in Transgenic Mice Is Efficient in Neurons but Inefficient in Astrocytes* , 1996, The Journal of Biological Chemistry.

[38]  D. Selkoe,et al.  Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Schellenberg,et al.  Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.

[40]  A. Vernadakis,et al.  GLIA-NEURON INTERCOMMUNICATIONS AND SYNAPTIC PLASTICITY , 1996, Progress in Neurobiology.

[41]  P. Mcgeer,et al.  Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein , 1996, Neuroscience Letters.

[42]  S. Younkin,et al.  Amyloid β protein (Aβ) removal by neuroglial cells in culture , 1995, Neurobiology of Aging.

[43]  S. Younkin.  Evidence that Aβ42 is the real culprit in alzheimer's disease , 1995 .

[44]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[45]  P. Whitehouse,et al.  Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. , 1995, Alzheimer disease and associated disorders.

[46]  C. Bieberich,et al.  The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice , 1995, Nature Genetics.

[47]  C. Finch,et al.  Response of striatal astrocytes to neuronal deafferentation: An immunocytochemical and ultrastructural study , 1994, Neuroscience.

[48]  L. Eng,et al.  GFAP and Astrogliosis , 1994, Brain pathology.

[49]  A. Nordberg.  Human nicotinic receptors—Their role in aging and dementia , 1994, Neurochemistry International.

[50]  J. Trojanowski,et al.  Paired helical filament tau in Alzheimer's disease. The kinase connection. , 1994, The American journal of pathology.

[51]  D. Selkoe,et al.  Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.

[52]  A. Yu,et al.  Astrocytic response to injury. , 1992, Progress in brain research.

[53]  J. Haines,et al.  Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. , 1992, American journal of human genetics.

[54]  N. Otsuka,et al.  Rapid appearance of β-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury , 1991, Brain Research.

[55]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[56]  D. Selkoe.  The molecular pathology of Alzheimer's disease , 1991, Neuron.

[57]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[58]  D. Selkoe,et al.  Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.

[59]  R. Martins,et al.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.

[60]  D. Mann,et al.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.

[61]  M. Lerman,et al.  Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. , 1987, Science.

[62]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[63]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[64]  H. Wiśniewski,et al.  Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome , 1985, Annals of neurology.